Preclinical studies for a cationic liposome formulation containing Il-2 Intended for the treatment of Human Tumors
Open Access
- 29 October 2018
- journal article
- Published by Heighten Science Publications Corporation in Archives of Pharmacy and Pharmaceutical Sciences
- Vol. 2 (1), 051-059
- https://doi.org/10.29328/journal.apps.1001010
Abstract
Human cervical cancer tumours expressing the IL-2 receptor (IL-2R) were induced in the peritoneal cavity of nude mice.This publication has 34 references indexed in Scilit:
- Peritoneal retention of liposomes: Effects of lipid composition, PEG coating and liposome chargeJournal of Controlled Release, 2010
- Evidence that cervical cancer cells secrete IL-2, which becomes an autocrine growth factorCytokine, 2010
- Cationic liposomes bearing IL-2 on their external surface induced mice leukocytes to kill human cervical cancer cellsin vitro, and significantly reduced tumor burden in immunodepressed miceJournal of Drug Targeting, 2010
- Characterization of cationic liposomes having IL-2 expressed on their external surface, and their affinity to cervical cancer cells expressing the IL-2 receptorJournal of Drug Targeting, 2009
- Management of peritoneal carcinomatosis secondary to metastatic cancer of unknown primary in menEuropean Journal of Cancer Care, 2009
- Biodistribution, pharmacokinetics and imaging of 188Re-BMEDA-labeled pegylated liposomes after intraperitoneal injection in a C26 colon carcinoma ascites mouse modelNuclear Medicine and Biology, 2007
- IL-2–mediated apoptosis of kidney tubular epithelial cells is regulated by the caspase-8 inhibitor c-FLIPKidney International, 2005
- Biodistribution and Pharmacokinetics of111In-DTPA-Labelled Pegylated Liposomes After Intraperitoneal InjectionActa Oncologica, 2003
- Interleukin 2 modulates ion secretion and cell proliferation in cultured human small intestinal enterocytesGut, 2001
- The expression and biological activity of IL-2 receptor on a human pancreas cancer cell lineBiotherapy, 1993